Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	QAW039 150 mg	296
Overall Study	STARTED	QAW039 450 mg	294
Overall Study	STARTED	Placebo	287
Overall Study	FAS/SAF: High Eosinophils Subpopulation	QAW039 150 mg	198
Overall Study	FAS/SAF: High Eosinophils Subpopulation	QAW039 450 mg	196
Overall Study	FAS/SAF: High Eosinophils Subpopulation	Placebo	193
Overall Study	FAS/SAF: Overall Population	QAW039 150 mg	296
Overall Study	FAS/SAF: Overall Population	QAW039 450 mg	293
Overall Study	FAS/SAF: Overall Population	Placebo	287
Overall Study	COMPLETED	QAW039 150 mg	277
Overall Study	COMPLETED	QAW039 450 mg	268
Overall Study	COMPLETED	Placebo	267
Overall Study	NOT COMPLETED	QAW039 150 mg	19
Overall Study	NOT COMPLETED	QAW039 450 mg	26
Overall Study	NOT COMPLETED	Placebo	20

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02563067/flow